Google News

Tarsus Pharmaceuticals Acquires Alkeus, Gildeuretinol for Stargardt Disease - The Clinical Trial Vanguard

Sep 5, 2026, 6:41 AM

Translate article text

Choose a language and wait for the translated text.

Tarsus Pharmaceuticals Acquires Alkeus, Gildeuretinol for Stargardt Disease  The Clinical Trial Vanguard